Track the 株式会社デ・ウエスタン・セラピテクス研究所 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社デ・ウエスタン・セラピテクス研究所 has published 31 insider filings. Market capitalisation: €4.3bn. The latest transaction was disclosed on 15 September 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald Europe. All data is accessible without an account.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,823 of 29,156 companies
31.9
score / 100
Value
13
Quality
50
FCF yld-12%
Earn yld-16%
EV/EBITDA·
ROE-56%
Gross mgn90%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
De Western Therapeutics Institute, Inc. is a Japanese company focused on research and development of innovative therapies in the health and pharmaceutical sector. It aims to create therapeutic solutions for various diseases.